Drug Licenses for Importers in IndiaForm 10, Form 41 & Wholesale Authorizations
End-to-end CDSCO regulatory licensing for pharmaceutical importers and global manufacturers. We manage Form 41 Registration Certificates, Form 10 Import Licenses, Form 11 Test Licenses, and Authorized Indian Agent (AIR) representation under the Drugs and Cosmetics Act.
Obtain Your Drug Import License
Connect with our CDSCO pharmaceutical regulatory experts for dossier scoping and timeline roadmaps.
How Drug Imports are Regulated in India
The importation of pharmaceutical products into India is governed by the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945, enforced by the Central Drugs Standard Control Organisation (CDSCO) under the Ministry of Health and Family Welfare.
To distribute imported pharmaceuticals lawfully in India, importers and foreign OEMs must complete a dual-layered regulatory process: first securing a Registration Certificate (Form 41) for the overseas manufacturing site and products, followed by obtaining a commercial Drug Import License (Form 10 or Form 10-A).
Prerequisite: Wholesale License & Authorized Agent
Foreign manufacturers without an Indian office must appoint an Authorized Indian Agent who holds valid Wholesale Drug Licenses (Form 20B/21B) from the State FDA to act as the legal registration holder and commercial liaison.
Therapeutic & Regulatory Classes Governed:
New Chemical Entities (NCE) & New Drugs
Active ingredients or pharmaceutical formulations not previously approved in India, requiring specialized clinical dossier review and Subject Expert Committee (SEC) presentations.
Active Pharmaceutical Ingredients (APIs)
Bulk drug substances intended for domestic finished formulation manufacturing, requiring complete Drug Master File (DMF) and Open Part submissions.
Fixed Dose Combinations (FDCs)
Formulations containing two or more therapeutic active ingredients in a fixed ratio, evaluated for medical rationale, synergy, and Indian therapeutic justification.
Phytopharmaceuticals & Biologics
Plant-derived purified botanical drugs, biosimilars, vaccines, recombinant therapeutics, and blood products with specialized cold-chain and central lab testing mandates.
Drug Import Licensing & Approvals Portfolio
NKB Regovanta delivers 360-degree regulatory execution across pre-market authorizations, import licenses, and post-market compliance.
Registration Certificate (Form 41)
Mandatory statutory registration issued by CDSCO confirming that the overseas drug manufacturing facility and products comply with Indian GMP and quality benchmarks. Filed via Form 40 on the SUGAM portal.
Drug Import License (Form 10 / 10-A)
Statutory license authorizing the commercial importation of bulk active pharmaceutical ingredients (APIs), finished formulations, and biological products into Indian territory.
Test License for Importers (Form 11)
Special permit granted under Form 11 (applied via Form 12) allowing the import of small trial quantities of drugs for examination, laboratory testing, clinical batch evaluation, or regulatory analysis.
Wholesale Drug License (Form 20-B / 21-B)
Mandatory prerequisite license granted by the State Licensing Authority (SLA) enabling the importer or local entity to store, warehouse, sell, and distribute pharmaceutical products across India.
Authorized Indian Agent (AIR) Support
Legal representation and registration holding service for overseas pharmaceutical manufacturers without an established physical subsidiary in India.
Rule 37 & Post-Approval Lifecycle
Statutory approvals for patent or proprietary medicines imported in bulk for retail packaging, shelf-life extensions, batch release tracking, and label adaptations under Indian Rules.
The 4-Stage Drug Import Approval Process
From corporate credentialing to final customs clearance, NKB Regovanta streamlines every step of your drug import licensing journey.
Wholesale License & Entity Setup
Securing State FDA Wholesale Licenses (Form 20B/21B) with registered pharmacist appointment and SUGAM corporate account configuration.
Registration Certificate (Form 40 → Form 41)
Dossier compilation (Plant Master File, GMP, DMF, COPP) and submission to CDSCO Central Licensing Authority for foreign site & product approval.
Form 9 Undertaking & Import License (Form 8 → Form 10)
Execution of statutory Form 9 authorization and filing Form 8 application to obtain the commercial Form 10 Import License.
Customs Clearance & Post-Import Governance
Facilitating Port Health Officer (PHO) sampling, central lab release, and ongoing compliance with pharmacovigilance and renewal calendars.
Frequently Asked Questions on Drug Import Licensing
Key insights into CDSCO procedures, Form 9 undertakings, wholesale licenses, and statutory timelines in India.
Planning to import pharmaceutical drugs or APIs into India?
Connect with NKB Regovanta’s pharmaceutical regulatory consultants for expert guidance on Form 41 site registration and Form 10 import licensing.